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Background
Antibody Dependent Cellular Cytotoxicity (ADCC) may
be a contributing factor of immune responses controlling
HIV-1 replication. Understanding the epitopes recog-
nized by ADCC-mediating antibodies is likely to be
important for the development of an effective AIDS
vaccine. We characterized the epitope specificity and
breadth of the ADCC-mediating antibody response
elicited by the RV144 vaccine regimen.
Methods
Twenty-three monoclonal antibodies (mAbs) were isolated
from 6 vaccine recipients either from IgG+ memory B cells
cultured at near clonal dilution for 14 days (n=115,200)
followed by sequential screenings of culture supernatants
for HIV-1 gp120 Env binding, or from memory B cell
(n=206,745) sorting for HIV-1 group M consensus
gp140Con.S Env binding. Target cells infected with infec-
tious molecular clones expressing Clade A/E (CM235),
B (BaL), and C (DU422 and DU151) env were used to
characterize the specificity and breadth of the 23 mAbs
that display ADCC activity. We defined the epitope speci-
ficity of the isolated mAbs by mapping with B.MN and/or
AE.92TH023 linear peptides in ELISA and with Fab-
competition in ADCC assays.
Results
Linear mapping revealed that 2 mAbs recognized the
V2, and 1 mAb the V3 regions of the gp120. Nineteen
(19) mAbs recognized conformational epitopes overlap-
ping the C1 A32 epitope; one mAb (CH20) recognized a
conformational epitope that was not blocked by any of
the Fabs (A32, 19B, 17b) utilized in our assay. Fourteen
of the 20 mAbs directed against conformational epitopes
mediated ADCC against the clade B BaL Env; 4 recog-
nized the clade C DU151 Env and 1 recognized the
clade C DU422 Env.
Conclusion
The RV144 vaccine regimen induced broadly-reactive
ADCC Abs that recognized both unique and overlap-
ping regions of gp120. The mAbs with the greatest
breadth may be useful for passive protection trials in
rhesus macaques. If protective in non-human primates,
the epitopes recognized by these mAbs may inform
immunogen design.
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